Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
194266,GNRL,"Pfizer Inc.",NY,100000000286,22.18,08/14/2013,GNRL,205737846
194266,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,20.14,02/13/2015,GNRL,255812782
194266,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,16.72,08/14/2014,GNRL,194711910
194266,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,16.03,09/16/2015,GNRL,320045888
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.73,11/24/2015,GNRL,267132350
194266,GNRL,"Actavis Pharma Inc",NJ,100000010642,15.51,10/13/2015,GNRL,339526678
194266,GNRL,"Shire North American Group Inc",MA,100000061292,15.37,12/09/2015,GNRL,301070463
194266,GNRL,"Pfizer Inc.",NY,100000000286,15.13,10/09/2013,GNRL,206056418
194266,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.94,02/26/2014,GNRL,196685692
194266,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,14.89,03/02/2015,GNRL,320045878
194266,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.71,03/16/2015,GNRL,290872532
194266,GNRL,"Astellas Pharma US Inc",IL,100000000137,14.61,06/16/2014,GNRL,168926306
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.27,01/15/2015,GNRL,266009296
194266,GNRL,"Pfizer Inc.",NY,100000000286,14.22,01/23/2014,GNRL,206264212
194266,GNRL,"Astellas Pharma US Inc",IL,100000000137,14.04,08/20/2013,GNRL,101662212
194266,GNRL,"Astellas Pharma US Inc",IL,100000000137,14.04,02/11/2014,GNRL,168426078
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.01,10/14/2014,GNRL,162381398
194266,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,14.01,08/31/2015,GNRL,320045882
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.97,04/30/2015,GNRL,266648530
194266,GNRL,"Astellas Pharma US Inc",IL,100000000137,13.75,04/07/2014,GNRL,168726706
194266,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.52,10/27/2015,GNRL,275765756
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.36,06/10/2015,GNRL,266770568
194266,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.31,09/24/2014,GNRL,196008374
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.97,06/26/2014,GNRL,161624606
194266,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,12.84,09/13/2013,GNRL,100363310
194266,GNRL,"Lilly USA, LLC",IN,100000000066,12.76,12/01/2015,GNRL,268142500
194266,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.66,03/31/2015,GNRL,256015986
194266,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,12.44,11/26/2014,GNRL,196685836
194266,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,12.23,08/20/2014,GNRL,152616260
194266,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.19,08/05/2014,GNRL,150015630
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.85,06/11/2014,GNRL,161421778
194266,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.85,03/09/2015,GNRL,275765758
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.82,04/03/2014,GNRL,161062858
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.82,02/13/2014,GNRL,160898962
194266,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.71,07/24/2014,GNRL,196685838
194266,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.63,01/22/2014,GNRL,196685694
194266,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.52,06/02/2015,GNRL,275765760
194266,GNRL,"Pfizer Inc.",NY,100000000286,11.51,05/04/2015,GNRL,323464044
194266,GNRL,"Amgen Inc.",CA,100000000203,11.46,08/17/2015,GNRL,297839400
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.40,12/22/2015,GNRL,267153018
194266,GNRL,"Actavis Pharma Inc",NJ,100000010642,11.40,12/22/2015,GNRL,339250240
194266,GNRL,"Astellas Pharma US Inc",IL,100000000137,11.37,10/01/2013,GNRL,101668654
194266,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,11.32,10/14/2015,GNRL,320045892
194266,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.20,05/16/2014,GNRL,196685690
194266,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.19,12/11/2013,GNRL,104338570
194266,GNRL,"Amgen Inc.",CA,100000000203,11.14,07/14/2014,GNRL,138203522
194266,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,10.85,04/23/2014,GNRL,201525686
194266,GNRL,"Lilly USA, LLC",IN,100000000066,10.85,12/07/2015,GNRL,268142502
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.85,02/16/2015,GNRL,266255372
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.81,05/13/2014,GNRL,161390036
194266,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.81,07/03/2014,GNRL,187946058
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.81,08/18/2015,GNRL,266990152
194266,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.79,12/09/2013,GNRL,13967262
194266,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.79,02/24/2014,GNRL,149376394
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.75,04/13/2015,GNRL,266701254
194266,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.71,03/11/2015,GNRL,337524546
194266,GNRL,"Novartis Pharmaceuticals Corporation",NJ,100000000228,10.70,12/02/2014,GNRL,152616262
194266,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,10.68,01/07/2014,GNRL,198489558
194266,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.65,11/18/2013,GNRL,23817402
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.44,11/25/2013,GNRL,32322911
194266,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.42,10/24/2013,GNRL,13967263
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.42,06/11/2015,GNRL,266788890
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.41,03/26/2015,GNRL,267175584
194266,GNRL,"Astellas Pharma US Inc",IL,100000000137,10.33,10/09/2014,GNRL,168636876
194266,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,10.33,09/28/2015,GNRL,319723004
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.32,03/04/2014,GNRL,160992614
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.32,01/20/2014,GNRL,160750292
194266,GNRL,"Amgen Inc.",CA,100000000203,10.32,06/15/2015,GNRL,297839398
194266,GNRL,"Shire US Holdings",PA,100000000241,10.31,10/10/2013,GNRL,6368916
194266,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.27,11/19/2014,GNRL,194711908
194266,GNRL,"Pfizer Inc.",NY,100000000286,10.27,04/16/2015,GNRL,323442812
194266,GNRL,"Shire North American Group Inc",MA,100000061292,10.25,07/16/2015,GNRL,300667506
194266,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.22,11/03/2014,GNRL,149866010
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.12,11/24/2014,GNRL,162279802
194266,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,10.09,01/15/2014,GNRL,199577002
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.07,08/28/2014,GNRL,161991668
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,9.78,07/07/2014,GNRL,161716194
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,9.66,09/25/2014,GNRL,162098658
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,9.53,02/06/2015,GNRL,266238560
194266,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,9.01,06/10/2014,GNRL,194711906
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.75,12/04/2014,GNRL,162397940
194266,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,8.38,09/22/2015,GNRL,337524638
194266,GNRL,"Novo Nordisk Inc",NJ,100000000144,7.82,09/17/2015,GNRL,267024666
194266,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,7.10,01/13/2014,GNRL,194711912
